Stock listing

NASDAQ:RXDX Prometheus Biosciences Inc Stock

Follow Prometheus Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RXDX

$199.92 USD

Close on Jun 16, 2023 · No longer trades

Mar 12, 2021 to last close +690.5% · weekly closes, Mar 12, 2021 – Jun 16, 2023
Lowest – highest close
$16.51 – $199.92 USDSince Mar 12, 2021 · lowest Mar 29, 2021 · highest Jun 15, 2023

Delisted NASDAQ:RXDX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RXDX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Prometheus Biosciences Inc on 6ix

Decks
1 deck · latest Dec 7, 2022

Decks

DeckKindSlidesDate
Technical Presentation (December 2022)Technical32 slidesDec 7, 2022

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bihua Chen
Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past)
Director · Mar 11, 2021 – Mar 11, 2021 · Past
Fred Hassan
Other companies: Recursion Pharmaceuticals, Inc. (Director · Since Oct 31, 2026); EyePoint, Inc. (Director · Since at least Sep 3, 2024); Cocrystal Pharma, Inc. (Director · Since at least Apr 20, 2023); BridgeBio Pharma, Inc. (Director · Since at least Aug 17, 2021); Precigen, Inc. (Director · Since at least Jun 30, 2016); Time Warner Inc (Director · Jun 1, 2016 – Jun 14, 2018 · Past); Amgen Inc. (Director · Jul 28, 2015 – May 5, 2020 · Past)
Director · May 14, 2021 – Jun 16, 2023 · Past
Mark McKenna
Other companies: Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Spyre Therapeutics, Inc. (Board Member · Since at least Feb 1, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past)
Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past
Joseph Papa
Other companies: Milestone Pharmaceuticals Inc. (Independent Non-Executive Director · Since at least Sep 3, 2024); Emergent BioSolutions Inc. (President and Chief Executive Officer · Since at least Feb 21, 2024); Candel Therapeutics, Inc. (Chairman · Since at least Aug 8, 2022); Bausch + Lomb Corporation (See Remarks, Director · May 5, 2022 – May 5, 2022 · Past); Bausch Health Companies Inc. (Director · May 2, 2016 – May 10, 2022 · Past); Perrigo Company plc (Director · Oct 9, 2006 – Feb 26, 2016 · Past)
Director · Mar 11, 2021 – Jun 16, 2023 · Past
Mark Stenhouse
Other companies: Phathom Pharmaceuticals, Inc. (Chief Operating Officer, Prometheus Biosciences · Since at least Mar 17, 2020); EXACT Sciences Corporation (President, Cologuard · Apr 2, 2018 – Apr 2, 2020 · Past)
Chief Operating Officer · Mar 11, 2021 – Jun 16, 2023 · Past
Judith L Swain
Other companies: Lexicon Pharmaceuticals, Inc. (Director · Since at least Sep 24, 2007)
Director · Mar 11, 2021 – Jun 16, 2023 · Past
Keith W Marshall
Other companies: Histogen Inc (EVP, COO & CFO · Aug 31, 2017 – May 22, 2020 · Past)
Chief Financial Officer · Mar 11, 2021 – Jun 16, 2023 · Past
Allison LuoChief Medical Officer · Mar 11, 2021 – Nov 14, 2021 · Past
Timothy K AndrewsGeneral Counsel · Mar 11, 2021 – Nov 14, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Prometheus Biosciences Inc.